The University of Queensland-based Protagonist Therapeutics, Inc. has announced the completion of a $14 million Series B venture financing initiative.
10 July 2013A successful Brisbane biotechnology company formed by The University of Queensland’s Institute for Molecular Bioscience (IMB) is expanding its collaboration with a publicly traded pharmaceutical company based on the east coast of the United States.
10 December 2012
